Advertisement

AAN: Marine Microplastic Levels Linked to Cognitive, Other Disabilities

0

Higher prevalence rates of cognitive, mobility, self-care, and independent living disability seen for coastal counties with very high versus low MMLs

Ultra-Rapid Molecular-Genetic Assays Feasible for Tumor Classification During Surgery

0

Ultra-rapid digital droplet PCR can measure the levels of tumor cells in a tissue sample in about 15 minutes

Longtime NIH Leader Francis Collins Retires

0
By I. Edwards HealthDay Reporter MONDAY, March 3, 2025 (HealthDay News) -- Dr. Francis Collins, the famed geneticist who led the National Institutes of Health...

RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public...

0

Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department

Nanosensor Assay Promising for Pancreatic Cancer Detection

0

In recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98 percent specificity and 73 percent sensitivity across all stages

PFAS ‘Forever Chemicals’ Worthy Of Public Concern, Expert Says

0
By Dennis Thompson HealthDay Reporter THURSDAY, Feb. 27, 2025 (HealthDay News) -- Average people are right to be worried about PFAS “forever chemicals” being found...

Stressors Affect Systemic Inflammation, Tumor Aggressiveness in Breast Cancer

0

Perceived stress, discrimination, neighborhood deprivation linked to systemic inflammation, aggressive tumor characteristics

Second Flu Vaccine Meeting Canceled — What Happens Next?

0
By India Edwards HealthDay Reporter THURSDAY, Feb. 27, 2025 (HealthDay News) -- A federal vaccine advisory panel work session focused on next year's flu shot...

Four Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALS

0

Four techniques offer good clinical performance for serum NfL quantification in diagnosis and prognosis of amyotrophic lateral sclerosis

Multimodal Computational Framework Can Predict Prognosis of Myelodysplastic Syndromes

0

In recent study, VAE-Surv achieved a median C-index of 0.78, outperforming classical approaches